why choose us

First received: January 26, 2024

Clinical Trial: Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors (MK-1200-002)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Advanced Solid Tumors

Study Type: INTERVENTIONAL


Official Title: A Phase 1/2 Open-label Study to Evaluate the Safety and Efficacy of MK-1200 in Participants With Advanced Solid Tumors

Brief Summary: The purpose of this study is to assess the efficacy and safety of MK-1200 monotherapy in participants with advanced/metastatic gastric/gastroesophageal junction (GEJ) cancer, esophageal cancer, biliary tract cancer, and pancreatic ductal adenocarcinoma who have received, or been intolerant to, all treatments known to confer clinical benefit.Part 1 of the study will be a dose escalation to determine the maximum tolerated dose (MTD).Part 2 will evaluate safety and efficacy of MK-1200 at 2 different doses

Read more